Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort

Abstract Prostate cancer is the second most common cancer in men and affects 1 in 9 men in the United States. Early screening for prostate cancer often involves monitoring levels of prostate-specific antigen (PSA) and performing digital rectal exams. However, a prostate biopsy is always required for...

Full description

Bibliographic Details
Main Authors: Elisa Benedetti, Kelsey Chetnik, Thomas Flynn, Christopher E. Barbieri, Douglas S. Scherr, Massimo Loda, Jan Krumsiek
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Data
Online Access:https://doi.org/10.1038/s41597-023-02750-7